Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $5.19B.
ENTERPRISE VALUE (EV)
$5.19B
Cogent Biosciences, Inc.
Market Cap
$5.26B
Enterprise Value (EV)
$5.19B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.26B | $5.19B |
| CRISPR Therapeutics AG (CRSP)vs › | $5.28B | $5.78B |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.22B | $4.99B |
| Doximity, Inc. (DOCS)vs › | $5.38B | $5.11B |
| Erasca, Inc. (ERAS)vs › | $5.14B | $5.14B |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.43B | $5.08B |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.09B | $5.46B |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.56B | $5.41B |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.94B | $5.37B |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.91B | $4.64B |
Market Cap
$5.26B
Total Debt
$238.80M
Cash
$312.01M
Enterprise Value
$5.19B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
